Skip to content

A study comparing covered stents versus standard balloon angioplasty for the treatment of blocked hemodialysis grafts.

A study comparing covered stents versus standard balloon angioplasty for the treatment of blocked hemodialysis grafts.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250929004
Enrollment
40
Registered
2025-09-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Anastomosis Stenosis of Dysfunctional Hemodialysis Access Grafts Venous Anastomotic Stenosis ,Hemodialysis Access Grafts ,Covered Stent

Interventions

After placing a 6Fr sheath and crossing the lesion with a wire, the stenotic lesion at the venous anastomosis is pre-dilated with a high-pressure balloon. A Covera vascular covered stent, typically 8
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Vascular Covered Stent,High-Pressure Balloon Angioplasty

Sponsors

Faculty of Medicine Ramathibodi Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients on hemodialysis using a forearm or upper arm arterio-venous graft who are diagnosed with venous anastomosis stenosis or occlusion. 2.Patients must have graft dysfunction, defined by National Kidney Foundation KDOQI guidelines (e.g., blood flow reduction, increased venous pressure, prolonged bleeding time, etc.). 3.The AV graft must have been placed more than 30 days prior and has been used at least once. 4.The length of the stenotic lesion must be less than or equal to 9 cm. 5.The diameter of the non-stenotic outflow vein is between 5-9 cm. 6.The patient provides informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Patient is unable to attend scheduled follow-up appointments. 2.Patient refuses to participate or withdraws from the study. 3.Presence of infection at the AV graft site. 4.Presence of central venous stenosis or occlusion. 5.The AV graft is located in the leg. 6.Patient has uncorrectable coagulopathy. 7.Patient has a known allergy to nickel or titanium.

Design outcomes

Primary

MeasureTime frame
Target Lesion Primary Patency 2 weeks, 3 months, 6 months, and 1 year post-procedure Clinically-driven reintervention or access abandonment, confirmed by Duplex Ultrasound or Angiography

Secondary

MeasureTime frame
Access Circuit Primary Patency 2 weeks, 3 months, 6 months, and 1 year post-procedure Freedom from repeat intervention in the access circuit or access circuit thrombosis, confirmed by clinical assessment and imaging,Postoperative Complications Within 30 days post-procedure Incidence of adverse events (e.g., access site complication, infection, allergic reaction, bleeding, thrombosis),Number of Reinterventions 2 weeks, 3 months, 6 months, and 1 year post-procedure Count of clinically-driven reintervention procedures required

Countries

Thailand

Contacts

Public ContactTin Artavatkun

Faculty of Medicine Ramathibodi Hospital

artavatin@gmail.com022011315

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026